Latest filing published 25 Jun 2019 for AIM ImmunoTech Inc., €8,852.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -54.4%Entry US$2,902.04 · Close at T+365 US$1,322.99
- +0.0%Entry US$2,091.17 · Close at T+365 US$2,091.17
- -25.9%Entry US$13,827.35 · Close at T+365 US$10,242.48
- -28.6%Entry US$28,678.95 · Close at T+365 US$20,484.97
- -16.9%Entry US$30,215.32 · Close at T+365 US$25,094.08
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David R. Strayer: trading record in brief
David R. Strayer is a declared insider of AIM ImmunoTech Inc., with filings sourced from SEC (Form 4). The record holds 21 filings, for trades running from 25 September 2008 to 21 June 2019.
Both buying and selling appear: 8 purchases worth €146k, against 3 sales worth €23k. Purchases outweigh sales by €124k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 8 share grants. Since January 2019: 1 purchase and no sales on the market.
A typical purchase (the median) is worth €5,703. Ninety days after publication, 7 purchases show a median change of +28.8%, with the price up in 71% of them. They describe history only and say nothing certain about the share price ahead.
Most recently, on 25 June 2019, the filings show an open-market purchase worth €8,852 in AIM ImmunoTech Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David R. Strayer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,481 shares@ US$4.03Common StockSEC:0001702626-19-000005:0Canonical exit: 19 Sept 2019 (T+90)
- 50,000 sharesCommon StockSEC:0001613377-19-000004:0
- 35,000 sharesCommon StockSEC:0001613377-19-000004:1
- 10 sharesSeries B Convertible Preferred StockSEC:0001583701-19-000002:0
- 50,000 sharesWarrantsSEC:0001583701-19-000002:1
- 2,500 shares0Common StockSEC:0001613377-18-000035:0
- 7,937 shares@ US$0.6351.6% of flowCommon StockSEC:0001613377-17-000006:0Canonical exit: 31 Jul 2017 (T+90)
- 9,892 shares@ US$0.4648.4% of flowCommon StockSEC:0001613377-17-000003:0Canonical exit: 17 May 2017 (T+90)
- 5,100 shares@ US$0.255Common StockSEC:0001270074-12-000003:0Canonical exit: 15 Aug 2012 (T+90)
- 44,900 shares@ US$0.255Common StockSEC:0001270074-12-000003:1Canonical exit: 16 Aug 2012 (T+90)
- 252 shares@ US$0.56Common StockSEC:0001270074-10-000002:0
- 40,900 shares@ US$0.55Common StockSEC:0001270074-10-000002:1
- 9,748 shares@ US$0.5501Common StockSEC:0001270074-10-000002:2
- 230,586 shares@ US$0.575Common StockSEC:0001270074-10-000001:0Canonical exit: 14 Sept 2010 (T+90)
- 12,000 shares@ US$0.5654Common StockSEC:0001270074-09-000005:0Canonical exit: 7 Mar 2010 (T+90)
- 20,067 shares@ US$0.39Incentive sharesSEC:0001270074-09-000004:0
- 43,962 shares@ US$0.18Incentive sharesSEC:0001270074-09-000003:0
- 54,015 shares@ US$0.14Incentive sharesSEC:0001270074-09-000002:0
- 58,089 shares@ US$0.13Incentive sharesSEC:0001270074-09-000001:0
- 54,453 shares@ US$0.14Incentive sharesSEC:0001270074-09-000001:1
- 28,500 shares@ US$0.35Common StockSEC:0001191435-08-000003:0Canonical exit: 24 Dec 2008 (T+90)
21 of 21 declarations